Document Detail

Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson's disease rodent model.
MedLine Citation:
PMID:  23339105     Owner:  NLM     Status:  In-Data-Review    
Mesenchymal stem cells (MSCs) could be an alternative to foetal cells in the treatment of several neurodegenerative diseases, especially Parkinson's disease (PD). We have previously demonstrated the functional efficacy of the undifferentiated bone marrow MSCs (BMMSCs) cultured in a xenofree conditions in PD animal models. We now demonstrate isolation of MSCs from the umbilical cord matrix tissue and assess their safety and efficacy to improve Parkinsonian symptoms in an in vivo animal model. The efficacy of MSCs from BM and umbilical cord in the PD animal mode has also been studied, and more importantly the efficacy of using differentiated UCMSC (D-UCMSCs) to dopaminergic phenotype. Phenotypically, UCMSCs expressed higher levels of SSEA4 compared to BMMSCs. Analysis of differentiated cells showed that D-UCMSCs expressed significant levels of Tyrosine Hydroxyalse and Nurr1 compared to D-BMMSCs. The in vivo efficacy of the differentiated and undifferentiated cell types in the Parkinsonian rats showed that D-UCMSCs improved the symptoms throughout a year of study. Differentiated cell types are potentially better for clinical use than the undifferentiated type, provided they are made available at the site of action in adequate numbers. MSCs are less immunogenic and immunomodulatory, which opens up the further possibility of using these cells in allogeneic settings. This could be a novel cell therapy application, especially when getting autochthonous cells is difficult.
Prathibha Shetty; Anirban M Thakur; Chandra Viswanathan
Related Documents :
24262755 - Ige receptor-mediated mast-cell renin release.
23424635 - Generation of megakaryocytic progenitors from human embryonic stem cells in a feeder- a...
22967315 - In silico-aided design of a glycan ligand of sialoadhesin for in vivo targeting of macr...
23092115 - Antioxidation of decellularized stem cell matrix promotes human synovium-derived stem c...
3496465 - Long-term depressed immune function in patients splenectomized for trauma.
11733565 - Bone marrow stromal cells mediate androgenic suppression of b lymphocyte development.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cell biology international     Volume:  37     ISSN:  1095-8355     ISO Abbreviation:  Cell Biol. Int.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9307129     Medline TA:  Cell Biol Int     Country:  England    
Other Details:
Languages:  eng     Pagination:  167-80     Citation Subset:  IM    
Copyright Information:
© 2013 International Federation for Cell Biology.
Regenerative Medicine, Reliance Life Sciences Pvt Ltd, Dhirubhai Ambani Life Sciences Centre R-282, TTC Industrial Area of MIDC, Thane Belapur Road, Rabale, Navi, Mumbai 400701, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Adventitial fibroblasts from apoE(-/-) mice exhibit the characteristics of transdifferentiation into...
Next Document:  Engineering Hierarchical Nanostructures by Elastocapillary Self-Assembly.